跳转至内容
Merck
CN

SML1072

Sigma-Aldrich

GSK-LSD1

≥98% (HPLC)

别名:

GSK-LSD1(反式外消旋) 二盐酸盐, rel-N-[(1R,2S)-2-苯基环丙基] -4-哌啶胺盐酸盐(1:2)

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C14H20N2 · 2HCl
分子量:
289.24
UNSPSC代码:
51111800
PubChem化学物质编号:
NACRES:
NA.77

质量水平

方案

≥98% (HPLC)

表单

powder

颜色

white to beige

溶解性

H2O: 20 mg/mL, clear

储存温度

2-8°C

SMILES字符串

C1(N[C@@H]2C[C@H]2C3=CC=CC=C3)CCNCC1

InChI

1S/C14H20N2/c1-2-4-11(5-3-1)13-10-14(13)16-12-6-8-15-9-7-12/h1-5,12-16H,6-10H2/t13-,14+/m0/s1

InChI key

BASFYRLYJAZPPL-UONOGXRCSA-N

应用

GSK-LSD1已用作小鼠中的赖氨酸特异性脱甲基酶 1(LSD1)抑制剂,用于研究败血症诱导的死亡率。它还被用作抑制剂,用于研究苯乙肼激活人类免疫缺陷病毒(HIV)潜伏期是否由 LSD1 引起。

生化/生理作用

GSK-LSD1 是赖氨酸特异性脱甲基酶 1(LSD1)的有效选择性抑制剂。GSK-LSD1 通过改变基因表达模式有效抑制不同癌细胞系的增殖。有关完整特征描述的详细信息,请访问 Structural Genomics Consortium(SGC)网站上的 GSK-LSD1 探针目录

要了解用于表观遗传目标的其他 SGC 化学探针,请访问 sigma.com/sgc

特点和优势

GSK-LSD1 是一种表观遗传化学探针,是与 Structural Genomics Consortium (SGC) 合作研发的。想要了解更多信息并查看其他SGC表观遗传探针,请访问sigma.com/SGC
这种化合物是基因调控研究的特色产品。点击此处发现更多特色基因调控产品。在sigma.com/discover-bsm可了解更多关于生物活性小分子的其他研究领域。

相关产品

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable


从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Bastian Ramms et al.
Diabetes, 71(12), 2513-2529 (2022-09-27)
The transition from lean to obese states involves systemic metabolic remodeling that impacts insulin sensitivity, lipid partitioning, inflammation, and glycemic control. Here, we have taken a pharmacological approach to test the role of a nutrient-regulated chromatin modifier, lysine-specific demethylase (LSD1)
HIV-1 infection of microglial cells in a reconstituted humanized mouse model and identification of compounds that selectively reverse HIV latency
Llewellyn GN, et al.
Journal of Neurovirology, 1-12 (2017)
PKCα-LSD1-NF-κB-Signaling Cascade Is Crucial for Epigenetic Control of the Inflammatory Response
Kim D, et al.
Molecular Cell, 69(3), 398-411 (2018)
Carl M Gay et al.
Cancer cell, 39(3), 346-360 (2021-01-23)
Despite molecular and clinical heterogeneity, small cell lung cancer (SCLC) is treated as a single entity with predictably poor results. Using tumor expression data and non-negative matrix factorization, we identify four SCLC subtypes defined largely by differential expression of transcription
Kimberly N Smitheman et al.
Haematologica, 104(6), 1156-1167 (2018-12-06)
Lysine specific demethylase 1 (LSD1) is a histone modifying enzyme that suppresses gene expression through demethylation of lysine 4 on histone H3. The anti-tumor activity of GSK2879552 and GSK-LSD1, potent, selective irreversible inactivators of LSD1, has previously been described. Inhibition

商品

We offer a variety of small molecule research tools, such as transcription factor modulators, inhibitors of chromatin modifying enzymes, and agonists/antagonists for target identification and validation in gene regulation research; a selection of these research tools is shown below.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门